Brucella abortus: Immunity, vaccines and prevention strategies based on nucleic acids;Brucella abortus: Inmunidad, vacunas y estrategias de prevención basadas en ácidos nucleicos

Archivos de Medicina Veterinaria

Volumn 38, Issue 1, 2006, Pages 7-18

  Rivers, R ^a   Andrews, E ^a   Gonzalez Smith A ^a   Donoso, G ^a   Onate A ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Brucella abortus; DNA vaccines; Prevention; RNA vaccines

Indexed keywords

BACTERIA (MICROORGANISMS); BOS TAURUS; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS;

EID: 33745880086     PISSN: 0301732X     EISSN: 0301732X     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Allardent-Servent A, G Bourg, M Ramuz, M Pages, M Bellis, G Roizes. 1988. DNA polymorphism in strains of the genus Brucella. J Bacteriol 170, 4603-4607.
2. Allen C, L Adams, T Fitch. 1998. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracelular survival. Infect Immun 66, 1008-1016.
3. a. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69, 4816-4822.
4. b. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun 69, 6264-6270.
5. Andersson C, N Vasconcelos, M Sievertzon, D Haddad, S Liljeqvist, P Berglund, P Liljeström, N Ahlborg, S Stahl, K Berzins. 2001. Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332. Scand J Immunol 54, 117-24.
6. Aréstegui M, C Gualtieri, J Domínguez, G Scharovsky. 2001. El género Brucella y su interacción con el sistema mononuclear fagocítico. Vet Méx 32, 131-139.
7. Bae J. 1999. Generation of baculovirus-Brucella abortus heat shock protein recombinants; mice immune responses against the recombinants, and B. abortus superoxide dismutase and L7/L12 recombinant proteins. Ph.D thesis. Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
8. Bae J, G Schuring, T Toth. 2002. Mice immune responses to Brucella abortus heat shock proteins use of vaculovirus recombinant-expressing whole insects cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens. Vet Microbiol 88, 189-202.
9. Baldwin C, T Sathiyaseelan, B Naiman, A White, R Brown, S Blumerman, A Rogers, S Black. 2002. Activation of bovine peripheral blood γδ T cells for cell division and IFN-γ production. Vet Immunol Immunopathol 87, 251-259.
10. Basner-Tschakarjan E, A Mirmohammadsadegh, A Baer, U Hengge. 2004. Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins. Gene Ther 11, 765-74.
11. Birmingham J, L Tabatabai, B Deyoe, E Jeska, M Nuessen. 1982. Generation of chemotactic factor for granulocytes and monocytes from serum by fractions of Brucella abortus. Immunology 46, 17-22.
12. Briones G, N Iñon de Iannino, M Roset, A Vigliocco, P Silva, R Ugalde. 2001. Brucella abortus cyclic β-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect Immun 69, 4528-4535.
13. Canning P, J Roth, L Tabatabai, B Deyoe. 1985. Isolation of components of Brucella abortus responsible for inhibition of function in bovine neutrophils. J Infect Dis 152, 913-921.
14. Caroff M, D Bundle, M Perry, J Cherwonogrodzky, J Duncan. 1984. Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3. Infect Immun 46, 384-388.
15. Celli J, Ch Chastellier, D Franchini, J Pizarro-Cerda, E: Moreno, J Gorvel. 2003 Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med 198, 545-556.
16. Céspedes S, E Andrews, H Folch, A Oñate. 2000. Identification and partial characterization of a new protective antigen of Brucella abortus. J Med Microbiol 49, 165-170.
17. Cloeckaert A, M Grayon, O Grepinet. 2000. An IS711 element downstream of the bp26 gene is a specific marker of Brucella spp. isolated from marine mammals. Clin Diagn Lab Immunol 7, 835-839.
18. Cloeckaert A, N Vizcaino, J Paquet, R Bowden, P Elzer. 2002. Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol 90, 229-47.
19. Corbeil L, K Blau, T Inzana, K Nielsen, R Jacobson, R Corbeil, A Winter. 1988. Killing of Brucella abortus by bovine serum. Infect Immun 56, 3251-3261.
20. Corbel M. 1997. Brucellosis: an overview. Emerg Infect Dis 3, 213-221.
21. DeTulleo L, T Kirchhausen. 1998. The clathrin endocytic pathway in viral infection. EMBO J 17, 4585-4593.
22. Dieli F, F Poccia, M Lipp, G Sireci, N Caccamo, C di Sano, A Salerno. 2003. Differentiation of effector/memory Vd2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med 198, 391-397.
23. Donnelly J, J Ulmer, J Shiver, M Liu. 1997. DNA vaccines. Annu Rev Immunol 15, 617-48.
24. Donnelly J, M Liu, J Ulmer. 2000. Antigen presentation and DNA vaccines. Amer J Resp Crit Care Med 162, 190-193.
25. Douglas J, E Rosenberg, H Nikaido, D Verstreate, A Winter. 1984. Porins of Brucella species. Infect Immun 44, 16-21.
26. Eisenschenk F, J Houle, E Hoffmann. 1999. Mechanism of serum resistance among Brucella abortus isolates. Vet Microbiol 68, 235-44.
27. Elzer P, R Philips, G Robertson, R Roop II. 1996. The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes. Infect Immun 64, 4838-4841.
28. Fernández D, C Baldwin. 1995. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun 63, 1130-1133.
29. Fernández D, R Benson, C Baldwin. 1995. Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice Infect Immun 63, 4029-4033.
30. Fernández-Prada C, M Nikolich, R Vemulapalli, N Sriranganathan, S Boyle, G Schurig, T Hadfield, D Hoover. 2001. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect Immun 69, 4407-4416.
31. Ficht T. 2003. Intracellular survival of Brucella: defining the link with persistence. Vet Microbiol 92, 213-223.
32. Ficht T, S Bearden, B Sowa, G Adams. 1989. DNA sequence and expression of the 36-kilodalton outer membrane protein gene of Brucella abortus. Infect Immun 57, 3281-3291.
33. Fiori P, S Mastrandrea, P Rappelli, P Cappuccinelli. 2000. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 38, 2005-2006.
34. Fleeton M, B Sheahan, E Gould,G Atkins, P Liljeström. 1999. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge. J Gen Virol 80,1189-1198.
35. Folch H, A Oñate. 1995. Propiedades mitogénicas y caracterización de diferentes fracciones polisacáridas obtenidas de dos especies de Brucella. Arch Med Vet 27, 85-92.
36. Forestier C, F Deleuil, N Lapaque, E Moreno, J Gorvel. 2000. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a downregulator of T cell activation. J Immunol 165, 5202-5210.
37. Frolov I, T Hoffman, B Pragai, S Dryga, HV Huang, S Schlesinger, CM Rice. 1996. Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci USA 93, 11371-11377
38. Gándara B, A López, M Rigel, E Martínez-Romero. 2001. Limited genetic diversity of Brucella spp. J Clin Microbiol 39, 235-240.
39. Giambartolomei G, M Delpino, M Cahanovich, J Wallach, P Balde, C Velikovsky, C Fossati. 2002. Diminished production of T helper 1 cytoquines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J Infect Dis 186, 252-259.
40. Golding B, D Scott, O Scharf, L Huang, M Zaitseva, C Lapham, N Eller, H Golding. 2001. Immunity and protection against Brucella abortus. Microbes Infect 3, 43-48.
41. Gurunathan S, D Klinman, R Seder. 2000. DNA vaccines: immunology, application, and optimization. Ann Rev Immunol 18, 927-974.
42. Guzmán I, E Andrews, A González, R Rivers, A Cabrera, A Oñate. 2004. Una vacuna ADN para la brucelosis bovina. Resúmenes del XIII Congreso Chileno de Medicina Veterinaria, Valdivia, pp. 30.
43. Guzmán-Berri C, E Chaves-Olarte, C von Eichel-Streibe, I López-Goñi, M Thelestam, S Arvidson, J Gorvel, E Moreno. 2001. GTPases of the Rho subfamily are sequired for Brucella abortus internalization in nonprofessional phagocytes. J Biol Chem 276, 44435-44443.
44. Halling S, B Peterson-Burch, B Bricker, R Zuerner, Z Qing, L Li, V Kapur, D Alt, S Olsen. 2005. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genome of Brucella melitensis and Brucella suis. J Bacteriology 187, 2715-2726.
45. nd ed. E. Lennette, E. Spaulding, J. Truant (eds.). American Society of Microbiology. Washington, D. C. Pgs. 295-301.
46. Helenius A, B Morein, E Fries, K Simons, P Robinson, V Schirrmacher, C Terhorst, J Strominger. 1978. Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Nat Acad Sci USA 75, 3846-3850.
47. Hinsdill R, D Berman. 1967. Antigens of Brucella abortus I. Chemical and Immunoelectrophoretic Characterization. J Bacteriol 93, 544-549.
48. Hong P, R Tsolis, T Ficht. 2000. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect Immun 68, 4102-4107.
49. Ilarmon B, L Adams, M Frey. 1988. Survival of rough and smooth strains of Brucella abortus in bovine mammary gland macrophages. Am J Vet Res 49, 1092-1097.
50. Ko J, G Splitter. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 16, 65-78.
51. Kurar E, G Splitter. 1997. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 15, 1851-1857.
52. Lopetegui P. 1998. Erradicación de brucellosis bovina en Chile. Experiencia en el uso de la vacuna cepa RB51. En: Luna- Martínez E, F Suárez-Guemes (eds). III Foro Nacional de brucelosis, Acapulco. Pp 159-179. Anonymous. México.
53. Lucero N, L Foglia, S Ayala, D Gall, K Nielsen. 1999. Competitive enzyme immunoassay for diagnosis of human brucellosis. J Clin Microbiol 37, 3245-3248.
54. Lundström K, A Mills, G Buell, E Allet, N Adami, P Liljeström. 1994. High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system. Eur J Biochem 224, 917-21.
55. Meyer M. 1964. The epizootiology of brucellosis and its relationship to the identificaction of Brucella organisms. Am J Vet Res 25, 553-557.
56. th ed. Vol 2., Pp. 2053-2057. Churchill Livingstone. Philadelphia, USA.
57. Meador V, B Deyoe. 1989 Intracellular Localization of Brucella abortus in bovine placenta. Vet Pathol 26, 513-515.
58. McDonel J. 1990. Brucella vaccines. In, A. Mizrahi, ed. Advances in Biotechnological Processes, Vol 13. Bacterial Vaccines. Pp. 105-122. Wiley-Liss Publishers, New York, NY.
59. Montaraz J, A Winter, D Hunter, D Sowa, A Wu, L Adams. 1986. Protection against Brucella abortus in mice with Opolysaccharide- specific monoclonal antibodies. Infect Immun 51, 961-963.
60. Moreno E. 2002. Brucellosis in Central América. Vet Microbiol 90, 31-38.
61. Moreno E, I Moriyón. 2002. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Nat Acad Sci 99, 1-3.
62. + T cells. Infect Immun 72, 2081-2087.
63. Murphy E, G Robertson, M Parent, S Hagius, R Roop II, P Elzer, C Baldwin. 2002. Major histocompatibility complex class I and II expression on macrophages containing a virulent strain of Brucella abortus measured using green fluorescent protein-expressing brucellae and flow cytometry. FEMS Immunol Med Microbiol 33, 191-200.
64. + T cells. Immunology 83, 659-664.
65. Oliveira S, G Splitter. 1996. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14, 959-962.
66. Oliveira S, J Harms, M Banai, G Splitter. 1996. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucellavaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell Immunol 172, 262-268.
67. Oliveira S, N Soeurt, G Splitter. 2002. Molecular and cellular interactions between Brucella abortus antigens and host immune responses. Vet Microbiol 90, 417-424.
68. Olkkonen V, P Liljeström, H Garoff, K Simons, C Dotti. 1993. Expression of heterologous proteins in cultured rat hippocampal neurons using the Semliki Forest virus vector. J Neurosci Res 35, 445-51.
69. Olsen S. 2000. Responses of adult cattle to vaccination with a reduced dose of Brucella abortus strain RB51. Res Vet Sci 69, 135-140.
70. Oñate A, H Folch. 1995. Proteína de 18.5 kDa: un antígeno interesante en Brucella. Arch Med Vet 27, 93-102.
71. Oñate A, R Vemulapalli, E Andrews, G Schurig, S Boyle, H Folch. 1999. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun 67, 986-988.
72. Oñate A, E Andrews, A Beltran, G Eller, G Schurig, H Folch. 2000. Frequent exposure of mice to crude Brucella abortus proteins down-regulates immune response. J Vet Med 47, 677-682.
73. Oñate A, S Céspedes, A Cabrera, R Rivers, A González, C Muñoz, H Folch, E Andrews. 2003. A DNA vaccine encoding Cu/Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 71, 4857-4861.
74. Oñate A, G Donoso, G Moraga-Cid, H Folch, S Céspedes, E Andrews. 2005. A RNA Vaccine Based on Recombinant Semliki Forest Virus Particles Expressing Cu/Zn Superoxide Dismutase Protein of Brucella abortus Induces Protective immunity in BALB/c Mice. Infect Immun 73, 3294-3300.
75. Pasquali P, R Adone, L Gasbarre, C Pistoia, F Ciuchini. 2001. Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infect Immun 69, 6541-6544.
76. Pasquali P, R Adone, L Gasbarre, C Pistoia, F Ciuchini. 2002. Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of brucella abortus 2308 infection in mice. Clin Diagn Lab Immunol 9, 491-492.
77. Pizarro-Cerda J, S Merece, R Parton, G van Der-Goot, A Sola- Landa, I Lopez-Goñi, E Moreno, J Gorvel. 1998. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun 66, 5711-5724.
78. Pontow S, V Kery, D Stahl. 1992. Mannose receptor. Int Rev Cytol 139, 221-224.
79. Ramírez M, J Sigal. 2002. Macrophages and Dendritic Cells use the cytosolic pathway to rapidly Cross-Present antigen from live, vaccinia-infected cells. J Immunol 169, 6733-6742.
80. Rivera S, M Ramírez, I Lopetegui. 2002. Eradication of bovine brucellosis in the 10th Region de Los Lagos, Chile. Vet Microbiol 90, 45-53.
81. Rodríguez A, A Orduña, X Ariza, I Moriyon, R Díaz, J Blasco, A Almaraz, F Martínez, C Ruiz, R Abad. 2001. Manual de Brucelosis. Ed. Junta de Castilla y León. Copyright. Zamora, España.
82. Roop II R, T Fletcher, N Sriranganathan, S Boyle, G Schurig. 1994. Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun 62, 1000-1007.
83. Santos J, D Verstreate, V Perera, A Winter. 1984. Outer membrane proteins from rough strains of four Brucella species. Infect Immun 46, 188-194.
84. Satkauskas S, M Bureau, A Mahfoudi, L Mir. 2001. Slow accumulation of plasmid in muscle cells: supporting evidence for a mechanism of DNA uptake by receptormediated endocytosis. Mol Ther 4, 317-323.
85. Sauret J, N Vilissova. 2002. Human Brucellosis. J. Am Board Fam Pract 15, 401-406.
86. Scharf O, I Agranovich, K Lee, N Eller, L Levy, J Inman, D Scott, B Golding. 2001. Ontogeny of Th1 memory responses against a Brucella abortus conjugate. Infect Immun 69, 5417-5422.
87. Schurig G, R Roop II, T Bagchi, S Boyle, D Buhrman, N Sriranganathan. 1991. Biological properties of RB51: a stable rough strain of Brucella abortus. Vet Microbiol 28, 171-188.
88. Schurig G, N Sriranganathan, M Corbel. 2002. Brucellosis vaccines: past, present and future. Vet Microbiol 90, 479-496.
89. Singh I, A Helenius. 1992. Role of ribosomes in Semliki Forest virus nucleocapsid uncoating. J Virol 66, 7049-7058.
90. Smerdou C, P Liljeström. 1999. Two-helper RNA system for production of recombinant Semliki Forest virus particles. J Virol 73, 1092-1098.
91. Smith H, R Fritzgeorge. The chemical basis of the virulence of Brucella abortus. V. 1964. The basis of intracellular survival and growth in bovine phagocytosis. Brit J Exp Path 45,174-186.
92. Splitter G, S Oliveira, M Carey, C Miller, J Ko, J Covert. 1996. T lymphocyte mediated protection against facultative intracellular bacteria. Vet Immunol Immunopathol 54, 309- 319.
93. Stevens M, S Olsen, G Pugh. 1994. Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19. Infect Immun 62, 4659-4663.
94. Stevens M, S Olsen. 1996. Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51. Infect Immun 64, 1030-1034.
95. Tabatabai L, S Hennager. 1994. Cattle serologically positive for Brucella abortus have antibodies to B. abortus Cu-Zn superoxide dismutase. Clin Diagn Lab Immunol 1, 506-510.
96. Tang D, M Devit, S Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-4.
97. Van Metre D, G Kennedy, S Olsen, G Hansen, D Ewalt. 1999. Brucellosis induced by RB51 vaccine in a pregnant heifer. J Am Vet Med Assoc 215, 1491-1493.
98. Vasselon T, P Detmers. 2002. Toll receptors: a central element in innate immune responses. Infect Immun 70, 1033-1041.
99. Velikovsky C, J Cassataro, G Giambartolomei, F Goldbaum,S Estein, R Bowden, L Bruno, C Ffossati, M Spitz. 2002. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 70, 2507-11.
100. Vemulapalli R, Y He, L Buccolo, S Boyle, N Sriranganathan, G Schurig. 2000a. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change rough phenotype and attenuation. Infect Immun 68, 3927-3932.
101. Vemulapalli R, S Cravero, C Calvert, T Toth, N Sriranganathan, S Boyle, O Rosseti, G Schurig. 2000b. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol 7, 114-118.
102. Vemulapalli R, Y He, S Cravero, N Sriranganathan, S Boyle, G Schurig. 2000c. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 68, 3286-3289.
103. Vemulapalli R, Y He, N Sriranganathan, S Boyle, G Schurig. 2002. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines. Vet Microbiol 90, 521-532.
104. Verger J, F Grimont, P Grimont, M. Grayon. 1985. Brucella a monospecific genus as shown by deoxyribonucleic acid hybridization. Int J Syst Bacteriol 35, 292-295.
105. Verstreate D, M Creasy, N Caveney, C Baldwin, M Blab, A Winter. 1982. Outer membrane proteins of Brucella abortus: isolation and characterization. Infect Immun 35, 979-989.
106. Verstreate D, A Winter. 1984. Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains. Infect Immun 46, 182-187.
107. WHO. The Development of New/Improved Brucellosis Vaccines: Report of WHO Meeting with the participation of the Food and Agricultural Organization of the United Nations (FAO) and the Office International des Epizooties (OIE). World Health Organization. Geneva, Switzerland 11-12 December 1997.
108. Wilkinson P. 1980. Leukocyte locomotion and chemotaxis: effects of bacteria and viruses. Rev Infect Dis 2, 293-318.
109. Willems W, G Kaluza, C Boschek, H Bauer, H Hager, H Schutz, H Feistner. 1979. Semliki forest virus: cause of a fatal case of human encephalitis. Science 203, 1127-1129.
110. Wyckoff III J. 2002. Bovine T lymphocyte responses to Brucella abortus. Vet Microbiol 90, 395-415.
111. Yagupsky P. 1999. Detection of Brucellae in blood cultures. J Clin Microbiol 37, 3437-3442.
112. Young E, J Borchert, F Kreutzer, D Musher. 1985. Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes. J Infect Dis 151, 682-690.
113. + T cells by Brucella infection or immunization with antigenis extracts. Infect Immun 63, 969-975.
114. Zhan Y, Z Liu, C Cheers. 1996. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 64, 2782-2786.